In the last six to seven days, a stream of good news on the COVID-19 vaccine front has been coming in. Many leading vaccine candidates for COVID-19 have shown promising results.
On Monday, there was news from Oxford University and British Pharma Giant AstraZeneca’s joint vaccine candidate – ChAdOx1 nCoV-19.
On Tuesday, China’s CanSino and Germany’s Pfizer BioNtech published the results of their early trials, and Last week, US biotech firm Moderna’s experimental vaccine – mRNA-1273 showed promising results.
In this episode of daily updates on the coronavirus pandemic, we will look into the preliminary results of these vaccine candidates in detail.
Like our work? Click here to support The Wire:
The founding premise of The Wire is this: if good journalism is to survive and thrive, it can only do so by being both editorially and financially independent. This means relying principally on contributions from readers and concerned citizens who have no interest other than to sustain a space for quality journalism. As a publication, The Wire will be firmly committed to the public interest and democratic values.
We publish in four different languages!
For English, visit www.thewire.in
for Hindi:
for Urdu:
for Marathi:
If you are a young writer or a creator, you can submit articles, essays, photos, poetry – anything that’s straight out of your imagination – to LiveWire, The Wire’s portal for the young, by the young.
You can also follow The Wire’s social media platforms and engage with us.
Facebook
Don’t forget to hit the subscribe button to never miss a video from The Wire!